Medical Device Investing Abiomed Announces Q3 FY 2017 Revenue of $114.7 Million, Up 34% Over Prior Year
Predictive Technology Group, Inc. (PRED) Announces Acquisition of US Patent Application for Method for Treating Patients with Stem Cells "Cleaned" via CRISPR
Cerus Announces First U.S. Blood Center Customer Submits Biologics License Application to the FDA to Allow for Interstate Export of INTERCEPT Platelet Components
